Quizartinib is an inhibitor for FLT3, which is used to treat AML in patients who have FLT3-ITD mutations. It’s for those who’ve already tried other treatments and haven’t gotten better. So, it stops FLT3 from sending messages that make cancer cells grow and live longer.
You can get this in tablets, and they come in two strengths: 17.7 mg or 26.5 mg. You’ll find the med in bottles, each with 28 tablets inside. The medication is available in packaging containing 28 tablets per bottle.
Reviews
There are no reviews yet.